Evidence check: Cardio Risk Check in the context of gut health

The concept that gut health directly influences cardiovascular risk is scientifically intriguing but not yet robustly validated for consumer tests. There is evidence for a gut–heart axis: certain gut bacteria produce TMAO (trimethylamine N-oxide), which has been linked to increased atherosclerosis risk. Additionally, gut-derived inflammatory molecules like lipopolysaccharides (LPS) may promote systemic inflammation. However, individual effects vary widely, and most commercial microbiome tests do not provide clinically validated cardiovascular risk assessments. Established risk factors—LDL cholesterol, HDL, triglycerides, blood pressure, smoking—remain far more predictive. A 'Cardio Risk Check' based solely on gut health is misleading unless combined with standard biomarkers. Evidence: mixed – mechanistic and animal studies exist, but prospective human trials with reproducible predictions are largely lacking. Consumers should view such tests as complementary, not a substitute for medical screening.